Bioactivity of Autologous Irradiated Renal Cell Carcinoma Vaccines Generated by Ex Vivo Granulocyte-Macrophage Colony-Stimulating Factor Gene Transfer
J.W. Simons(Johns Hopkins University), Fray F. Marshall(Johns Hopkins University), Karen M. Hauda(Johns Hopkins University), William G. Nelson(Johns Hopkins University), Glenn Dranoff(Dana-Farber Cancer Institute), S Clift, Elizabeth M. Jaffee(Bloomberg (United States)), Christine E. Weber(Howard Hughes Medical Institute), Richard C. Mulligan(Whitehead Institute for Biomedical Research), Drew M. Pardoll(Bloomberg (United States)), H.J. Levitsky(Howard Hughes Medical Institute), Lisa A. Beck(University of Rochester Medicine), Steven Piantadosi(Brigham and Women's Hospital), Albert H. Owens(Johns Hopkins University), A Lazenby(University of Alabama at Birmingham), Laura K. Cohen(Howard Hughes Medical Institute), Michael A. Carducci(Sidney Kimmel Comprehensive Cancer Center), K M Leiferman(Mayo Clinic), C. C. Finn(Johns Hopkins University)
Cited by 80
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k